We can accommodate custom requests for your SARS-CoV-2 experiments.Contact us
IDT offers a wide array of primer and probe sets for your SARS-CoV-2 research.
Luminex Corporation has designed an RT-PCR assay for the detection of SARS-CoV-2. IDT manufactures RUO primers and probes identical to published sequences for this assay.
Advances in gene synthesis mean that subunit vaccines can be developed quickly from one or more antigen-presenting viral genes or peptide sequences, which circumvents the need for scientists to handle live and potentially dangerous pathogens, and eliminates the time needed to clone DNA fragments.
Targeted next generation sequencing (NGS) can quickly generate genomic data for viral infection identification, virus genome analysis, and surveillance of virus mutations. xGen™ NGS represents our commitment to accelerating your next breakthrough in COVID-19 research. Explore the new combined portfolio of Swift and IDT NGS products for sequencing the SARS-CoV-2 genome.
We can help with your Cas13 guide RNA needs. With fast turnaround, customizable scales and modifications, and multiple sizes in tubes or plates, we’re ready to support the identification of RNA viruses, such as SARS-CoV-2.
Our Affinity Plus (locked nucleic acid) antisense oligonucleotides (ASOs) are perfect reagents for knocking down SARS-CoV-2 gene expression for functional assessment or your research dedicated to the development of potential treatments for COVID-19.
For media inquiries about IDT’s role in the fight against COVID-19, please contact:IDT Public Relations, firstname.lastname@example.org